ArticleFrontiers in medicine2026
An XGBoost-based model for detecting undiagnosed type 2 diabetes using routine physical and lifestyle data from a multi-center Chinese population.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This study aimed to develop and validate an interpretable machine learning model to identify individuals with undiagnosed type 2 diabetes (T2D) using data readily available from routine health checkups. Methods: In this retrospective study, we analyzed data from 12 tertiary hospitals in China. Following the application of inclusion and exclusion criteria, data from 11,382 individuals formed the training set for developing an XGBoost model, which was optimized using 5-fold cross-validation. An independent test set of 1,026 individuals from the same multi-center data source was used for internal validation. Model performance was primarily assessed using the area under the receiver operating characteristic curve (AUC). Results: The final model incorporated 12 predictors. Fasting blood glucose was the most influential predictor (50.6%), followed by creatinine (6.6%), triglyceride (5.6%), age (5.1%), and low-density lipoprotein (5.0%). On the independent test set, the model achieved an AUC of 77.2% (95%CI: 70.3%-84.1%). Conclusion: The XGBoost model demonstrated moderate predictive performance for T2D risk using routine checkup data. This approach shows potential for integration into clinical practice as an assistive screening tool, enabling automated risk profiling during standard health examinations. By flagging high-risk individuals, it can support clinicians in decision-making regarding further diagnostic testing. Future work should focus on external validation and prospective implementation studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.